Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klaveness

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Carbohydrate Research|July 30, 1991
Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation propertiesP Rongved, J Klaveness
Carbohydrate Research|July 30, 1991
Cross-linked, degradable starch microspheres as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis, degradation, and relaxation propertiesP Rongved, B Lindberg, J Klaveness
Magnetic Resonance Imaging|January 1, 1990
Relaxation efficacy of paramagnetic and superparamagnetic microspheres in liver and spleenA K Fahlvik, E Holtz, J Klaveness
Chemotherapy|December 23, 2000
Chelating agentsT Bergan, J Klaveness, A J Aasen
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Abdominal imagingD D Stark, A K Fahlvik, J Klaveness
European Radiology|January 1, 1997
Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT. A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements)A Valentine, J A Jakobsen, A J Klaveness
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Iron oxides as MR imaging contrast agentsA K Fahlvik, J Klaveness, D D Stark
Investigative Radiology|July 1, 1990
Magnetic starch microspheres, biodistribution and biotransformation. A new organ-specific contrast agent for magnetic resonance imagingA K Fahlvik, E Holtz, U Schrøder, et al.
European Radiology|January 1, 1997
Delayed CT of the kidneys after iopentol (Imagopaque 350) injection in patients with normal renal function. An assessment of the gradual decrease in opacification over 32 h after injectionD Rickards, J A Jakobsen, A J Klaveness, et al.
Magnetic Resonance Imaging|January 1, 1997
Low-molecular weight lanthanide contrast agents: evaluation of susceptibility and dipolar effects in red blood cell suspensionsS Fossheim, K E Kellar, A K Fahlvik, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Carbohydrate Research|July 30, 1991
Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation propertiesP Rongved, J Klaveness
Carbohydrate Research|July 30, 1991
Cross-linked, degradable starch microspheres as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis, degradation, and relaxation propertiesP Rongved, B Lindberg, J Klaveness
Magnetic Resonance Imaging|January 1, 1990
Relaxation efficacy of paramagnetic and superparamagnetic microspheres in liver and spleenA K Fahlvik, E Holtz, J Klaveness
Chemotherapy|December 23, 2000
Chelating agentsT Bergan, J Klaveness, A J Aasen
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Abdominal imagingD D Stark, A K Fahlvik, J Klaveness
European Radiology|January 1, 1997
Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT. A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements)A Valentine, J A Jakobsen, A J Klaveness
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Iron oxides as MR imaging contrast agentsA K Fahlvik, J Klaveness, D D Stark
Investigative Radiology|July 1, 1990
Magnetic starch microspheres, biodistribution and biotransformation. A new organ-specific contrast agent for magnetic resonance imagingA K Fahlvik, E Holtz, U Schrøder, et al.
European Radiology|January 1, 1997
Delayed CT of the kidneys after iopentol (Imagopaque 350) injection in patients with normal renal function. An assessment of the gradual decrease in opacification over 32 h after injectionD Rickards, J A Jakobsen, A J Klaveness, et al.
Magnetic Resonance Imaging|January 1, 1997
Low-molecular weight lanthanide contrast agents: evaluation of susceptibility and dipolar effects in red blood cell suspensionsS Fossheim, K E Kellar, A K Fahlvik, et al.
Pageof 4